61314-225 : Timolol Gfs 5 mg/ml Ophthalmic Solution, Gel Forming, Extended Release


NDC: 61314-225
Labeler: Falcon Pharmaceuticals, Ltd.
Product Type: Human Prescription Drug
Drug Name:  Timolol Gfs
Dosage Form: Ophthalmic Solution, Gel Forming, Extended Release
Application #: NDA020963
Rev. Date: 


NDC Package Codes:

  • 61314-225-05: 5 ML IN 1 BOTTLE (61314‑225‑05)
  • 61314-225-25: 2.5 ML IN 1 BOTTLE (61314‑225‑25)

Active Ingredients:

  • Timolol Maleate

Dosage Strength:

  • 5 mg/mL

Pharmaceutical Classes:

  • Adrenergic beta-Antagonists [MoA]
  • beta-Adrenergic Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 61314-224 Timolol Gfs 2.5 mg/ml Ophthalmic Solution, Gel Forming, Extended Release by Falcon Pharmaceuticals, Ltd.
  • 72162-2185 Timolol Gfs 5 mg/ml Ophthalmic Solution, Gel Forming / Drops by Bryant Ranch Prepack

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61314-225 QR Code

< Prev: 61314-224Next: 61314-226 >

Related Discussions:

Dorzolamide-timolol opth
Has anyone taken the generic verision of Dorzolamide-Timolol and is it as good as the non-generic verision? Thanks. s. h... 1 reply
Dorzolamide - Timolol Opth Soln 10 ML
I have been on Dorzolamide - Timolol for the past eight months , for use in one eye . This drug has reduced my eye press... 1 reply
Istalol timolol maleate ophthalmic solution
glaucoma...
Is there any new eye drops for glaucoma iop control I am already using latanoprost xalatan and timolol maleate and Alphagan
I am using all the three drops but i feel my iop is still not under control. Would there be any new drug out in market ?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.